knowledge -WSS

knowledge

author：Wikipedia 2025-08-10 11:41:39 - browse：95

Novo Nordisk Denmark — LISELOTTE SABROE/AFP/Getty Images

An oral version of semaglutide, the drug marketed as Ozempic and Wegovy, led to dramatic weight loss in a trial enrolling people with obesity, manufacturer Novo Nordisk said Monday, data that could bolster what is already a blockbuster medicine.

In the study, which enrolled nearly 700 adults classified as having overweight or obesity, patients treated with a daily semaglutide tablet lost 15.1% of their body weight over the course of 17 months, while those on placebo lost 2.4%, Novo Nordisk said. The result is comparable to weekly injections of Wegovy, which in an earlier study led to 14.9% weight loss over the same period of time. In both studies, the most common side effects were gastrointestinal distress, with the majority of cases graded mild or moderate, the company said.

Novo Nordisk said it plans to submit oral semaglutide for U.S. and E.U. approvals later this year. A lower-dose version of the drug is already approved as a treatment for type 2 diabetes under the brand name Rybelsus.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Listen: PBM conflicts, RSV vaccines, & the future of flu season

Wikipedia

WSS

Australia's humpback populations rebound raising hopes of marine scientists

Crinetics acromegaly drug succeeds in late

The (many) problems with a new study criticizing cancer screening

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

How to fix cancer clinical trials' diversity problem

AstraZeneca chief proposes a novel edit to the drug pricing bill

explore

knowledge

explore

Medicare proposal to cover medical devices draws a mixed reaction

Why is France rioting? What to know about the fatal police shooting of Nahel M

Anesthesiologist group: stop taking Ozempic before surgery

Inside the fall of star MIT scientist David Sabatini

Sports medicine is finally prioritizing gender equality

When is a doctor not a doctor? Try when patients address women doctors

Hollywood unions extend contract negotiations for actors

A new House health package & hospitals’ new site

At least 13 dead in Texas as scorching temps continue

Brain 'hot spot' may explain why African Americans feel greater pain

knowledge

Why Novartis is changing the name of its research labs

Did the public have the right to know Arthur Ashe had AIDS?

Connecting traumatic brain injury and domestic violence

House transparency, PBM reform bill gains bipartisan support

Van's Gluten Free Original Waffles recalled for possible wheat allergen

7 people shot in DC, police say

knowledge

Wikipedia

leisure time

focus